Yeah ok. Facts are a bit fuzzy with MacNally. Good chance your insider information will wind up bit being inaccurate, not your fault of course. BTW MacNally said design changes were due to feedback from the pre clinical trials. Your saying it's due to issues in the lab. So which is it? Are you confirming that MacNally is misleading investors?